I. Persson

Plasma proteomics of biomarkers for inflammation or cancer cannot predict relapse in chronic myeloid leukaemia patients stopping tyrosine kinase inhibitor therapy.

U. Olsson‐Strömberg, S. Mustjoki, J. Richter, 2020, Leukemia research.

Safety and efficacy of the combination of pegylated interferon-α2b and dasatinib in newly diagnosed chronic-phase chronic myeloid leukemia patients

U. Olsson‐Strömberg, S. Mustjoki, M. Höglund, 2016, Leukemia.

Plasma proteomics in CML patients before and after initiation of tyrosine kinase inhibitor therapy reveals induced Th1 immunity and loss of angiogenic stimuli.

U. Olsson‐Strömberg, S. Mustjoki, J. Richter, 2016, Leukemia research.

Prevention of schizophrenia relapse with extended release quetiapine fumarate dosed once daily: a randomized, placebo-controlled trial in clinically stable patients.

J. Peuskens, M. Brecher, D. Meulien, 2007, Psychiatry (Edgmont (Pa. : Township)).

Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126).

T. Suppes, E. Vieta, M. Brecher, 2008, Journal of affective disorders.

P.3.c.058 Efficacy and safety of quetiapine in combination with lithium/divalproex as maintenance treatment for bipolar I disorder

E. Vieta, M. Brecher, I. Eggens, 2007, European Neuropsychopharmacology.